Hyperbaric oxygen therapy as an anti-infective agent

References

• Chang N, Goodson WH 3rd, Gottrup F, Hunt TK. Direct measurement of wound and tissue oxygen tension in postoperative patients. Ann. Surg.197(4), 470–478 (1983).
   PubMed Web of Science ®Google Scholar
• Rabkin J, Hunt TK. Local heath increases blood flow and oxygen tension in wounds. Arch. Surg.122(2), 221–225 (1987).
   PubMedGoogle Scholar
• Feldmeier JJ. Hyperbaric oxygen 2003: Indications and Results: The Hyperbaric Oxygen Therapy Committee Report. Undersea and Hyperbaric Medical Society, Kensington, MD, USA (2003).
   Google Scholar
• Plafki C, Peters P, Almeling M, Welslau W, Busch R. Complications and side effects of hyperbaric oxygen therapy. Aviat. Space Environ. Med.71(2), 119–124 (2000).
   PubMedGoogle Scholar
• Evanger K, Haugen OH, Irgens A, Aanderud L, Thorsen E. Ocular refractive changes in patients receiving hyperbaric oxygen administered by oronasal mask or hood. Acta Ophthalmol. Scand.82(4), 449–453 (2004).
   PubMedGoogle Scholar
• Yildiz S, Aktas S, Cimsit M, Ay H, Togrol E. Seizure incidence in 80,000 patient treatments with hyperbaric oxygen. Aviat. Space Environ. Med.75(11), 992–994 (2004).
   PubMedGoogle Scholar
• Thorsen E, Aanderud L, Aasen TB. Effects of a standard hyperbaric oxygen treatment protocol on pulmonary function. Eur. Respir. J.12(6), 1442–1445 (1998).
   PubMed Web of Science ®Google Scholar
• Feldmeier JJ, Heimbach RD, Davolt DA, Brakora MJ. Hyperbaric oxygen and the cancer patient: a survey of practice patterns. Undersea Hyperb. Med.20(4), 337–345 (1993).
   PubMed Web of Science ®Google Scholar
• Feldmeier J, Carl U, Hartmann K, Sminia P. Hyperbaric oxygen: does it promote growth or recurrence of malignancy? Undersea Hyperb. Med.30(1), 1–18 (2003).
   PubMed Web of Science ®Google Scholar
• Korhonen K. Hyperbaric oxygen therapy in acute necrotizing infections with a special reference to the effects on gas tissue tensions. Ann. Chir. Gynecol.214, 7–36 (2000).
   Google Scholar
• Park MK, Muhvich KH, Myers RAM, Marzella L. Effects of hyperbaric oxygen in infectious diseases: basic mechanisms. In: Hyperbaric Medicine Practice. Kindwall EP, Whelan HT (Eds). Best Publishing, Flagstaff, AZ, USA, 141–172 (2004).
   Google Scholar
• Gottlieb SF, Solosky JA, Aubrey R, Nedelkoff DD. Synergistic action on increased oxygen tensions and PABA–folic acid antagonists on bacterial growth. Aerospace Med.45(8), 829–833 (1974).
   PubMedGoogle Scholar
• Park MK, Muhvich KH, Myers RAM, Marzella L. Hyperoxia prolongs the aminoglicoside-induced postantibiotic effect in Pseudomomas aeruginosa. Antimicrob. Agents Chemother.35(4), 691–695 (1991).
   PubMed Web of Science ®Google Scholar
• Brown OR. Reversible inhibition of respiration of Escherichia coli by hyperoxia. Microbios.5(17), 7–16 (1972).
   PubMedGoogle Scholar
• Muhvich KH, Park MK, Myers RAM, Marzella L. Hyperoxia and the antimicrobial susceptibility of Escherichia coli and Pseudomonas aeruginosa. Antimicrob. Agents Chemother.33(9), 1526–1530 (1989).
   PubMed Web of Science ®Google Scholar
• Pakman LM. Inhibition of Pseudomonas aeruginosa by hyperbaric oxygen. I. Sulfonamide activity enhancement and reversal. Infect. Immun.4(4), 479–487 (1971).
   PubMed Web of Science ®Google Scholar
• Mader JT, Guckian JC, Glass DL, Reinarz JA. Therapy with hyperbaric oxygen for experimental osteomyelitis due to Staphylococus aureus in rabbits. J. Infect. Dis.138, 312–318 (1978).
   PubMed Web of Science ®Google Scholar
• Mader JT, Brown GL, Guckian JC, Wells CH, Reinarz JA. A mechanism for the amelioration by hyperbaric oxygen of experimental staphylococcal ostomyelitis in rabbits. J. Infect. Dis.142(6), 915–922 (1980).
   PubMed Web of Science ®Google Scholar
• Luongo C, Imperatore F, Matera MG et al. Effect of hyperbaric oxygen therapy in experimental subcutaneous and pulmoneray infections due to Pseudomonas aerugionasa. Undersea Hyperb. Med.26(1), 21–25 (1999).
   PubMed Web of Science ®Google Scholar
• Thom SR, Mendiguren I, Hardy K et al. Inhibition of human neutrophil b2-integrin-dependent adherence by hyperbaric O2. Am. J. Physiol.272(3 Pt 1), C770–C777 (1997).
   PubMedGoogle Scholar
• Fildissis G, Venetsanou K, Myrianthefs P, Karatzas S, Zidianakis V, Baltopoulos G. Whole blood pro-inflammatory cytokines and adhesion molecules post-lipopolysaccharides exposure in hyperbaric conditions. Eur. Cytokine Netw.15(3), 217–221 (2004).
   PubMed Web of Science ®Google Scholar
• Benson RM, Minter LM, Osborne BA, Granowitz EV. Hyperbaric oxygen inhibits stimulus-induced proinflammatory cytokine synthesis by human blood-derived monocyte-macrophages. Clin. Exp. Immunol.134(1), 57–62 (2003).
   PubMed Web of Science ®Google Scholar
• Bryant AE, Bayer CR, Huntington JD, Stevens DL. Group A streptococcal myonecrosis: increased vimentin expression after skeletal–muscle injury mediates the binding of Streptococcus pyogenes. J. Infect. Dis.193(12), 1685–1692 (2006).
   PubMed Web of Science ®Google Scholar
• Hickey MJ, Kwan RY, Awad MM et al. Molecular and cellular basis of microvascular perfusion deficits induced by Clostridium perfringensand Clostridium septicum. PLoS Pathog.4(4), e1000045 (2008).
   Web of Science ®Google Scholar
• Jaeger K, Juttner B, Sommer C et al. Effects of repetitive exposure to hyperbaric oxygen (HBO) on leukocyte function. Anasthesiol. Intensivmed. Notfallmed. Schmerzther.37(1), 24–28 (2002).
   PubMed Web of Science ®Google Scholar
• Bitterman N, Bitterman H, Kinarty A, Melamed Y, Lahat N. Effect of a single exposure to hyperbaric oxygen on blood mononuclear cells in human subjects. Undersea Hyperb. Med.20(3), 197–204 (1993).
   PubMed Web of Science ®Google Scholar
• Lahat N, Bitterman H, Yaniv N, Kinarty A, Bitterman N. Exposure to hyperbaric oxygen induces tumour necrosis factor-a (TNF-a) secretion from rat macrophages. Clin. Exp. Immunol.102(3), 655–659 (1995).
   PubMed Web of Science ®Google Scholar
• Bodnar BM, Pasternak II, Sydorchuk II et al. Influence of hyperbaric oxygenation on clinico–immunologic indices in children with acute diffuse peritonitis. Klin. Khir.5, 25–27 (2001).
   Google Scholar
• van den Blink B, van der Kleij AJ, Versteeg HH, Peppelenbosch MP. Immunomadulatory effect of oxygen and pressure. Comp. Biochem. Physiol. A Moll. Integr. Physiol.132(1), 193–197 (2002).
   PubMed Web of Science ®Google Scholar
• Granowitz EV, Skulsky EJ, Benson RM et al. Exposure to increased pressure or hyperbaric oxygen suppresses interferon-g secretion in whole blood cultures of healthy humans. Undersea Hyperb. Med.29(3), 216–225 (2002).
   PubMed Web of Science ®Google Scholar
• Jain KK, Bozzuto TM, Neubauer V, Tao HY. Hyperbaric medicine around the world. In: Textbook of Hyperbaric Medicine. 4th Edition. Jain KK (Ed.). Hogrefe & Huber Publishers, Germany, 459–464 (2004).
   Google Scholar
• Shugin W, Huiming Z. Influence of hyperbaric oxygen on phagocytic function of leukocyte in human being. Undersea Biomed. Res.17(Suppl.), 84 (1990).
   Google Scholar
• Badway JA, Karnovsky MK. Active oxygen species and the functions of phagocytic leukocytes. Ann. Rev. Biochem.49, 695–726 (1980).
   PubMed Web of Science ®Google Scholar
• Hohn DC, MacKay RD, Halliday B, Hunt TK. Effect of O2 tension on microbicidal function of leukocytes in wounds and in vitro. Surg. Forum27, 18–20 (1976).
   PubMedGoogle Scholar
• Hunt TK, Linsey M, Guislis G, Sonne M, Jawetz E. The effect of differing ambient oxygen tensions on wound infection. Ann. Surg.181, 35–39 (1975).
   PubMed Web of Science ®Google Scholar
• Kinghton DR, Halliday B, Hunt TK, Oxygen as an antibiotic. A comparison of the effects of inspired oxygen concentration and antibiotic administration on in vivo bacterial clearence. Arch. Surg.121, 191–195 (1986).
   PubMedGoogle Scholar
• Knighton DR, Fiegel VD, Halverson T, Schneider S, Brown T, Wells CL. Oxgen as an antibiotic. The effect of inspired oxygen on bacterial clearence. Arch. Surg.125, 97–100 (1990).
   PubMedGoogle Scholar
• Jonsson K, Hunt TK, Mathes SJ. Effect of environmental oxygen on bacterial-induced tissue necrosis in flaps. Surg. Forum35, 589–591 (1984).
   Google Scholar
• Park MK, Myers RA, Marzella L. Oxygen tensions and infections: modulation of microbial growth, activity of antimicrobial agents, and immunologic responses. Clin. Infect. Dis.15(2), 372–373 (1992).
   PubMed Web of Science ®Google Scholar
• Mendel V, Reichert B, Simanowski HJ, Scholz HC. Therapy with hyperbaric oxygen and cefazolin for experimental osteomyelitis due to Staphylococcus aureusin rats. Undersea Hyperb. Med.26(3), 169–174 (1999).
   PubMed Web of Science ®Google Scholar
• Raval G, Park MK, Myers RAM, Marzella L. Hyperoxia modulates aminoglycoside activity in Gram-negative bacteria. Undersea Biomed. Res.19, 26 (1992).
   Google Scholar
• Park MK, Myers RA, Marzella L. Hyporoxia and prolongation of aminoglicoside-induced postantibiotic effect in Pseudomonas aeruginosa: role of reactive oxygen species. Antimicrob. Agents Chemother.37, 120–122 (1993).
   PubMed Web of Science ®Google Scholar
• Morrisey I, Smith JT. The importance of oxygen in the killing of bacteria by ofloxacin and ciprofloxacin. Microbios78, 43–53 (1994).
   Google Scholar
• Muhvich KH, Anderson LH, Mehm WJ. Evaluation of antimicrobials combined with hyperbaric oxygen in a mouse model of clostridial myonecrosis. J. Trauma.36(1), 7–10 (1994).
   PubMedGoogle Scholar
• Öztas E, Kılıc A, Özyurt M, Korkmaz A, Basustaoğlu A. Effects of hyperbaric oxygen and penicillin in a murine model of streptococcal myositis. Undersea Hyperb. Med.28(4), 181–186 (2001).
   PubMed Web of Science ®Google Scholar
• Ardic N, Yildiz S, Cimsit M et al. The effect of hyperbaric oxygenation on the in vitro growth of Escherichia coli in environments with and without blood cells. Ann. Microb.56(1), 77–79 (2006).
   Web of Science ®Google Scholar
• Turhan V, Sancar S, Uzun G et al. Hyperbaric oxygen as adjunctive therapy in experimental mediastinitis. J. Surg. Res.155(1), 111–115 (2009).
   PubMed Web of Science ®Google Scholar
• Neal GD, Gates GA. Invasive Pseudomonas osteitis of the temporal bone Am. J. Otol.4(4), 332–337 (1983).
   PubMedGoogle Scholar
• Sheftel TG, Mader JT, Pennick JJ, Cierny G 3rd. Methicillin resistant Staphylococcus aureus osteomyelitis. Clin. Orthop.198, 231–239 (1985).
   PubMedGoogle Scholar
• Çimşit M, Aktaş Ş. Adjunctive hyperbaric oxygen therapy contributes healing in electrical injury: a case report of high voltage electrical injury. Ulus. Travma Acil. Cerrahi. Derg.11(2), 172–177 (2005).
   PubMedGoogle Scholar
• Körpınar Ş, Çimşit M. Farklı Wagner derecelerindeki diyabetik ayak ülserlerinde multidisipliner tedavi sonuçları. Presented at: 1. Ulusal Yara Bakımı Kongresi, Antalya, 15–18 November 2006.
   Google Scholar
• Krenk L, Nielsen HIJ, Christensen ME. Necrotizing fasciitis in the head and neck region: an analysis of standard treatment effectiveness. Eur. Arch. Otorhinolaryngol.264(8), 917–922 (2007).
   PubMed Web of Science ®Google Scholar
• Tally FP, Sullivan CE. Metronidazole: in vitro activity, pharmacology and efficacy in anaerobic bacterial infections. Pharmacotherapy1(1), 28–38 (1981).
   PubMed Web of Science ®Google Scholar
• Stevens DL, Bryant AE, Adams K, Mader JT. Evaluation of therapy with hyperbaric oxygen for experimental infection with clostridium perfringes. Clin. Infect. Dis.17(2), 231–237 (1993).
   PubMed Web of Science ®Google Scholar
• Brady CE 3rd, Cooley BJ, Davis JC. Healing of severe perineal and cataneous Crohn’s disease with hyperbaric oxygen. Gastroenterology97(3), 756–760 (1989).
   PubMed Web of Science ®Google Scholar
• Lavy A, Weisz G, Adir Y, Ramon Y, Melamed Y, Eidelman S. Hyperbaric oxygen for perianal Crohn’s disease. J. Clin. Gastroenterol.19(3), 202–205 (1994).
   PubMed Web of Science ®Google Scholar
• Jordan J, Piotrowski S, Piotrowski G, Kwiatek M. Hyperbaric oxygen therapy in case of the neck diffuse phlegmon with very hard clinical course. Otolaryngol. Pol.50(1), 8–16, (1996).
   PubMedGoogle Scholar
• Hitchcock CR, Demello FJ, Haglin JJ. Gangrene infection: new approaches to an old disease. Surg. Clin. North Am.55(6), 1403–1410, (1975).
   PubMed Web of Science ®Google Scholar
• Van Unnika. Inhibition of toxin production in Clostridium perfringensin vitro by hyperbaric oxygen. Antonie Leeuwenhoek Microbiology31, 181–186 (1965).
   PubMedGoogle Scholar
• Hirn M, Niinikoski J, Lehtonen OP. Effect of hyperbaric oxygen and surgery on experimental gas gangrene. Eur. Surg. Res.24(6), 356–362 (1992).
   PubMed Web of Science ®Google Scholar
• Hirn M, Niinikoski J, Lehtonen OP. Effect of hyperbaric oxygen and surgery on experimental multimicrobial gas gangrene. Eur. Surg. Res.25(5), 265–269 (1993).
   PubMed Web of Science ®Google Scholar
• Unsworth IP, Sharp PA. Gas gangrene. An 11-year review of 73 cases managed with hyperbaric oxygen. Med. J. Aust.140(5), 256–260 (1984).
   PubMed Web of Science ®Google Scholar
• Hart GB, Lamb RC, Strauss MB. Gas gangrene. J. Trauma.23(11), 991–1000 (1983).
   PubMedGoogle Scholar
• Korhonen K, Klossner J, Hirn M, Niinikoski J. Management of clostridial gas gangrene and the role of hyperbaric oxygen. Ann. Chir. Gynaecol.88(2), 139–142 (1999).
   PubMedGoogle Scholar
• Heimbach RD. Gas gangrene. In: Hyperbaric Medicine Practice. Kindwall EP, Whelan HT (Eds). Best Publishing, Flagstaff, AZ, USA, 549–573 (2004).
   Google Scholar
• Bakker D. Clostridial myonecrosis. In: Hyperbaric Surgery. Bakker D, Cramer F. (Eds). Best Publishing, Flagstaff, AZ, USA, 283–316 (2002).
   Google Scholar
• Tibbles PM, Edelsberg JS. Hyperbaric-oxygen therapy. N. Engl. J. Med.334(25), 1642–1648 (1996).
   PubMed Web of Science ®Google Scholar
• Levine EG, Manders SM. Life-threatening necrotizing fasciitis. Clin. Dermatol.23(2), 144–147 (2005).
   PubMed Web of Science ®Google Scholar
• Katz AR, Morens DM. Severe streptococal infections in historical perspective. Clin. Infect. Dis.14, 298–307 (1992).
   PubMed Web of Science ®Google Scholar
• Sudarsky LA, Laschinger JC, Coppa GF et al. Improved results from a standardized approach in treating patients with necrotizing fasciitis. Ann. Surg.206, 661–665 (1987).
   PubMed Web of Science ®Google Scholar
• McHenry CR, Piotrowski JJ, Petrinic D et al. Determinants of mortality for necrotizing soft-tissue infections. Ann. Surg.221, 558–565 (1995).
   PubMed Web of Science ®Google Scholar
• Bisno AL, Cockerill FR 3rd, Bermudez CT. The initial outpatient–physician encounter in group A streptococcal necrotizing fasciitis. Clin. Infect. Dis.31(2), 607–608 (2000).
   PubMed Web of Science ®Google Scholar
• Stone HH, Martin JD. Synergistic necrotizing cellulitis. Ann. Surg.175, 702–711 (1972).
   PubMed Web of Science ®Google Scholar
• Brown DR, Davis NL, Lepawsky M et al. A multicenter review of the treatment of major truncal necrotizing infections with and without hyperbaric oxygen therapy. Am. J. Surg167, 485–489 (1994).
   PubMed Web of Science ®Google Scholar
• Mulla ZD, Gibbs SG, Aronoff DM. Correlates of length of stay, cost of care, and mortality among patients hospitalized for necrotizing fasciitis. Epidemiol. Infect.135(5), 868–876 (2007).
   PubMed Web of Science ®Google Scholar
• Elliott DC, Kufera JA, Myers RA. Necrotizing soft tissue infections. Risk factors for mortality and strategies for management. Ann. Surg.224(5), 672–683 (1996).
   PubMed Web of Science ®Google Scholar
• Jacoby I. Clostridial myositis, necrotising fasciitis, and zygomycotic infections. In: Physiology and Medicine of Hyperbaric Oxygen Therapy. Neuman T, Thom S (Eds). Saunders, Philadelphia, PA, USA, 397–418 (2008).
   Google Scholar
• Korhonen K, Hirn M, Niinikoski J. Hyperbaric oxygen in the treatment of Fournier’s gangrene. Eur. J. Surg.164(4), 251–255 (1998).
   PubMedGoogle Scholar
• Anwar MU, Haque AK, Rahman J, Morris R, McDermott J. Early radical surgery and antimicrobial therapy with hyperbaric oxygen in necrotizing fasciitis. Plast. Reconstr. Surg.121(1), 360–361 (2008).
   PubMed Web of Science ®Google Scholar
• Escobar SJ, Slade JB Jr, Hunt TK, Cianci P. Adjuvant hyperbaric oxygen therapy (HBO2) for treatment of necrotizing fasciitis reduces mortality and amputation rate. Undersea Hyperb. Med.32(6), 437–443 (2005).
   PubMed Web of Science ®Google Scholar
• Risemann JF, Zamboni WA, Curtis A et al. Hyperbaric oxygen therapy for necrotising soft tissue infection reduces mortality and the need for debridements. Surgery108, 847– 850 (1990).
   PubMed Web of Science ®Google Scholar
• Shupak A, Shoshani O, Goldenberg I et al. Necrotising soft tissue infection: an indication for hyperbaric oxygen therapy? Surgery118, 873– 878 (1995).
   PubMed Web of Science ®Google Scholar
• Jallali N, Withey S, Butler PE. Hyperbaric oxygen as adjuvant therapy in the management of necrotizing fasciitis. Am. J. Surg.189(4), 462–466 (2005).
   PubMed Web of Science ®Google Scholar
• Tehrani MA, Ledingham MCA. Necrotising fasciitis. Postgrad. Med. J.53, 237–242 (1977).
   PubMed Web of Science ®Google Scholar
• Kaide CG, Khandelwal S. Hyperbaric oxygen: applications in infectious disease. Emerg. Med. Clin. North. Am.26(2), 571–595 (2008).
   PubMed Web of Science ®Google Scholar
• Eltorai IM, Hart GB, Strauss MB et al. The role of hyperbaric oxygen in the management of Fournier’s gangrene. Int. Surg.71, 53–58 (1986).
   PubMed Web of Science ®Google Scholar
• Leach RM, Rees PJ, Wilmshurst P. Hyperbaric oxygen therapy. Br. Med. J.317(7166), 1140–1143 (1998).
   PubMed Web of Science ®Google Scholar
• Gibbons GW. The diabetic foot: amputations and drainage of infection. J. Vasc. Surg.5(5), 791–793 (1987).
   PubMed Web of Science ®Google Scholar
• Reiber GE, Boyko EJ, Smith DG. Lower extremity foot ulcers and amputations in diabetes. In: Diabetes in America. Harris MI, Cowie CC, Stern MP et al. (Eds). US Department of Health and Human Services, Public Health Service, NIH, Washington, DC, USA (1995).
   Google Scholar
• Lipsky BA. New developments in diagnosing and treating diabetic foot infections. Diabetes Metab. Res. Rev.24(Suppl. 1), S66–S71 (2008).
   Google Scholar
• Knighton DR, Silver IA, Hunt TK. Regulation of wound-healing angiogenesis-effect of oxygen gradients and inspired oxygen concentration. Surgery90(2), 262–270 (1981).
   PubMed Web of Science ®Google Scholar
• Nylander G, NordstroÈm H, Eriksson E. Effects of hyperbaric oxygen on edema formation after a scald burn. Burns10, 193–196 (1984).
   Web of Science ®Google Scholar
• LaVan FB, Hunt TK. Oxygen and wound healing. Clin. Plast. Surg.17, 463–472 (1990).
   PubMed Web of Science ®Google Scholar
• Mader JT, Adams KR, Wallace WR. Hyperbaric oxygen as adjunctive therapy for osteo-myelitis. Infect. Dis. Clin. North. Am.4, 433–440 (1990).
   PubMedGoogle Scholar
• Baroni G, Porro T, Faglia E et al. Hyperbaric oxygen in diabetic gangrene treatment. Diabetes Care10, 81–94 (1987).
   PubMed Web of Science ®Google Scholar
• Faglia E, Favales F, Aldeghi A et al. Change in major amputation rate in a center dedicated to diabetic foot care during the 1980s: prognostic determinants for major amputation. J. Diabetes Complicat.12(2), 96–102 (1998).
   PubMed Web of Science ®Google Scholar
• Abidia A, Laden G, Kuhan G et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomised-controlled trial. Eur. J. Vasc. Endovasc. Surg.25(6), 513–518 (2003).
   PubMed Web of Science ®Google Scholar
• Kalani M, Jorneskog G, Nazanin N, Lind F, Brismar K. Hyperbaric oxygen therapy in the treatment of diabetic foot ulcers. Long term follow-up. J. Diabetes Complicat.16, 153–158 (2002).
   PubMed Web of Science ®Google Scholar
• Caputo GM, Cavanagh PR, Ulbrecht JS, Gibbons GW, Karchmer AW. Assessment and management of foot disease in patients with diabetes. N. Engl. J. Med.331, 854–860 (1994).
   PubMed Web of Science ®Google Scholar
• Andriole VT, Nagel DA, Southwick WO. A paradigm for human chronic osteomyelitis. J. Bone J. Surg. Am.55, 1511–1515 (1973).
   PubMed Web of Science ®Google Scholar
• Scheman L, Janota M, Lewin P. The production of experimental osteomyelitis. JAMA117, 1525–1529 (1941).
   Google Scholar
• Hart BB. Refractory osteomyelitis. In: Hyperbaric Oxygen 2003: Indications and Results: the Hyperbaric Oxygen Therapy Committee Report. Feldmeier JJ (Ed.). Undersea and Hyperbaric Medical Society, Kensington, MD, USA, 79–85 (2003).
   Google Scholar
• Morrey BF, Dunn JM, Heimbach RD et al. Hyperbaric oxygen and chronic osteomyelitis. Clin. Orthop. Rel. Res.144, 121–127 (1979).
   Google Scholar
• Davis JC. The results of refractory osteomyelitis treated with surgery, parenteral antibiotics, and hyperbaric oxygen. Clin. Ortho.205, 310 (1986).
   Google Scholar
• Maynor ML, Moon RE, Camporesi EM et al. Chronic osteomyelitis of the tibia: treatment with hyperbaric oxygen and autogenous microsurgical muscle transplantation. J. South Orthop. Assoc.7(1), 43–57 (1998).
   PubMedGoogle Scholar
• Menon S, Bharadwaj R, Chowdhary A, Kaundinya DV, Palande DA. Current epidemiology of intracranial abscesses: a prospective 5 year study. J. Med. Microbiol.57(Pt 10), 1259–1268 (2008).
   PubMed Web of Science ®Google Scholar
• Jacoby I. Intracranial abscess. In: Hyperbaric Oxygen 2003: Indications and Results: the Hyperbaric Oxygen Therapy Committee Report. Feldmeier JJ (Ed.). Undersea and Hyperbaric Medical Society, Kensington, MD, USA, 63–67 (2003).
   Google Scholar
• Lampl L, Frey G. Hyperbaric oxygen in intracranial abscess. In: Hyperbaric Medicine Practice. Kindwall E, Whelan H (Eds). Best Publishing, Flagstaff, AZ, USA, 645–543 (2002).
   Google Scholar
• Kutlay M, Colak A, Yildiz S, Demircan N, Akin ON. Stereotactic aspiration and antibiotic treatment combined with hyperbaric oxygen therapy in the management of bacterial brain abscesses. Neurosurgery57(6), 1140–1146 (2005).
   PubMed Web of Science ®Google Scholar
• Kurschel S, Mohia A, Weigl V, Eder HG. Hyperbaric oxygen therapy for the treatment of brain abscess in children. Childs Nerv. Syst.22(1), 38–42 (2006).
   PubMed Web of Science ®Google Scholar
• Kontoyiannis DP, Lewis RE. Invasive zygomycosis: update on pathogenesis, clinical manifestations,and management. Infect. Dis. Clin. North Am.20(3), 581–607 (2006).
   PubMed Web of Science ®Google Scholar
• John BV, Chamilos G, Kontoyiannis DP. Hyperbaric oxygen as an adjunctive treatment for zygomycosis. Clin. Microbiol. Infect.11(7), 515–517 (2005).
   PubMed Web of Science ®Google Scholar
• Yohai RA, Bullock JD, Aziz AA, Markert RJ. Survival factors in rhino-orbital-cerebral mucormycosis. Surv. Ophthalmol.39(1), 3–22 (1994).
   PubMed Web of Science ®Google Scholar
• Segal E, Menhusen MJ, Shawn S. Hyperbaric oxygen in the treatment of invasive fungal infections: a single-center experience. Isr. Med. Assoc. J.9(5), 355–357 (2007).
   PubMed Web of Science ®Google Scholar